Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules Now Available


 

Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules Now Available

On March 22, 2016, the NIH Office of Science Policy (OSP) published a Federal Register notice detailing the revised procedures for the review of human gene transfer trials subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines).  These changes are effective as of April 27, 2016.  A version of the April 2016 NIH Guidelines can now be found on the OSP website.  OSP has also added a number of additional resources to assist institutions in complying with the revised NIH Guidelines.  These resources include:

     RAC Revisions Fact Sheet

    FAQs on the NIH Review Process for Human Gene Transfer Trials (April 2016)

     FAQs on the NIH Guidelines Vaccine Exemption (April 2016)

If you have any questions about the revisions to the NIH Guidelines, or about the educational resources above, please feel free to email the NIH Office of Science Policy at SciencePolicy@od.nih.gov

Published: Thursday, April 28, 2016

Last Updated: Friday, March 9, 2018

Back to Top